Intravenous Penciclovir for Treatment of Herpes Simplex Infections in Immunocompromised Patients: Results of a Multicenter, Acyclovir-Controlled Trial

The efficacy and safety of penciclovir (PCV) for the treatment of herpes simplex virus (HSV) infections in immunocompromised (IC) patients were studied in a double-blind, acyclovir (ACV)-controlled, multicenter study. A total of 342 patients with mucocutaneous HSV infections received 5 mg of PCV per...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Lazarus, Hillard M., Belanger, Robert, Candoni, Anna, Aoun, Mickaël, Jurewicz, Regina, Marks, Lynn
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 1999
נושאים:
Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC89132/
https://ncbi.nlm.nih.gov/pubmed/10223935
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים